Learn More
We establish global well-posedness and scattering for solutions to the mass-critical nonlinear Schrödinger equation iut +∆u = ±|u| 4/d u for large spherically symmetric L 2 x (R d) initial data in dimensions d ≥ 3. In the focusing case we require that the mass is strictly less than that of the ground state. As a consequence, we obtain that in the focusing(More)
We consider the minimal mass m 0 required for solutions to the mass-critical nonlinear Schrödinger (NLS) equation iut + ∆u = µ|u| 4/d u to blow up. If m 0 is finite, we show that there exists a minimal-mass solution blowing up (in the sense of an infinite spacetime norm) in both time directions, whose orbit in L 2 x (R d) is compact after quotienting out by(More)
We establish global well-posedness and scattering for solutions to the defocusing mass-critical (pseudoconformal) nonlinear Schrödinger equation iut + ∆u = |u| 4/n u for large spherically symmetric L 2 x (R n) initial data in dimensions n ≥ 3. After using the reductions in [32] to reduce to eliminating blowup solutions which are almost periodic modulo(More)
Let d ≥ 4 and let u be a global solution to the focusing mass-critical nonlinear Schrödinger equation iut + ∆u = −|u| 4 d u with spherically symmetric H 1 x initial data and mass equal to that of the ground state Q. We prove that if u does not scatter then, up to phase rotation and scaling, u is the solitary wave e it Q. Combining this result with that of(More)
We consider the defocusing ˙ H 1-critical nonlinear Schrödinger equation in all dimensions (n ≥ 3) with a quadratic potential V (x) = ± 1 2 |x| 2. We show global well-posedness for radial initial data obeying ∇u 0 (x), xu 0 (x) ∈ L 2. In view of the potential V , this is the natural energy space. In the repulsive case, we also prove scattering. We follow(More)
Honokiol, a major bioactive constituent of the bark of Magnolia officinalis has been confirmed to have the neuroprotective effect on ischemic stroke in rats. This study was designed to observe the therapeutic time window of honokiol microemulsion on cerebral ischemia-reperfusion injury to support its potential for future clinical trials and further explore(More)